Enzymatica AB Statistics

Total Valuation

Enzymatica AB has a market cap or net worth of SEK 626.26 million. The enterprise value is 582.56 million.

Market Cap	626.26M
Enterprise Value	582.56M

Important Dates

The last earnings date was Thursday, July 17, 2025.

Earnings Date	Jul 17, 2025
Ex-Dividend Date	n/a

Share Statistics

Enzymatica AB has 242.74 million shares outstanding. The number of shares has increased by 36.84% in one year.

Current Share Class	242.74M
Shares Outstanding	242.74M
Shares Change (YoY)	+36.84%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	4.22%
Owned by Institutions (%)	14.41%
Float	113.79M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	12.45
PB Ratio	4.36
P/TBV Ratio	7.97
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-10.99
EV / Sales	11.58
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-9.05

Financial Position

The company has a current ratio of 7.07, with a Debt / Equity ratio of 0.01.

Current Ratio	7.07
Quick Ratio	5.46
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	-0.02
Interest Coverage	-60.62

Financial Efficiency

Return on equity (ROE) is -49.53% and return on invested capital (ROIC) is -27.31%.

Return on Equity (ROE)	-49.53%
Return on Assets (ROA)	-24.48%
Return on Invested Capital (ROIC)	-27.31%
Return on Capital Employed (ROCE)	-36.79%
Revenue Per Employee	2.39M
Profits Per Employee	-2.52M
Employee Count	21
Asset Turnover	0.37
Inventory Turnover	1.11

Taxes

In the past 12 months, Enzymatica AB has paid 60,000 in taxes.

Income Tax	60,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +37.71% in the last 52 weeks. The beta is 0.05, so Enzymatica AB's price volatility has been lower than the market average.

Beta (5Y)	0.05
52-Week Price Change	+37.71%
50-Day Moving Average	2.81
200-Day Moving Average	2.54
Relative Strength Index (RSI)	39.56
Average Volume (20 Days)	52,526

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Enzymatica AB had revenue of SEK 50.29 million and -52.99 million in losses. Loss per share was -0.23.

Revenue	50.29M
Gross Profit	33.25M
Operating Income	-53.04M
Pretax Income	-52.93M
Net Income	-52.99M
EBITDA	-50.35M
EBIT	-53.04M
Loss Per Share	-0.23

Full Income Statement

Balance Sheet

The company has 45.29 million in cash and 1.59 million in debt, giving a net cash position of 43.70 million or 0.18 per share.

Cash & Cash Equivalents	45.29M
Total Debt	1.59M
Net Cash	43.70M
Net Cash Per Share	0.18
Equity (Book Value)	143.73M
Book Value Per Share	0.59
Working Capital	63.70M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -64.07 million and capital expenditures -273,000, giving a free cash flow of -64.34 million.

Operating Cash Flow	-64.07M
Capital Expenditures	-273,000
Free Cash Flow	-64.34M
FCF Per Share	-0.27

Full Cash Flow Statement

Margins

Gross margin is 66.13%, with operating and profit margins of -105.47% and -105.37%.

Gross Margin	66.13%
Operating Margin	-105.47%
Pretax Margin	-105.25%
Profit Margin	-105.37%
EBITDA Margin	-100.12%
EBIT Margin	-105.47%
FCF Margin	n/a

Dividends & Yields

Enzymatica AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-36.84%
Shareholder Yield	n/a
Earnings Yield	-8.46%
FCF Yield	-10.27%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	4